| 0 | 💬 0 |
Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against Respiratory Syncytial Virus, Administered 12 Months Following a Primary Dose in Adults Aged >/=50 Years.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-04-30 | #vaccination #rna #immunogenicity #safety #rsv |